Cargando…

Role of Oncology Advanced Practitioners to Enhance Clinical Research

BACKGROUND: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance value across the spectrum of cancer care. Research is an underd...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun-Inglis, Christa, Boehmer, Leigh M., Zitella, Laura J., Hoffner, Brianna, Shvetsov, Yurii B., Berenberg, Jeffrey L., Oyer, Randall A., Benson, Al B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955568/
https://www.ncbi.nlm.nih.gov/pubmed/35369396
http://dx.doi.org/10.6004/jadpro.2022.13.2.2
_version_ 1784676367956180992
author Braun-Inglis, Christa
Boehmer, Leigh M.
Zitella, Laura J.
Hoffner, Brianna
Shvetsov, Yurii B.
Berenberg, Jeffrey L.
Oyer, Randall A.
Benson, Al B.
author_facet Braun-Inglis, Christa
Boehmer, Leigh M.
Zitella, Laura J.
Hoffner, Brianna
Shvetsov, Yurii B.
Berenberg, Jeffrey L.
Oyer, Randall A.
Benson, Al B.
author_sort Braun-Inglis, Christa
collection PubMed
description BACKGROUND: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance value across the spectrum of cancer care. Research is an underdeveloped component of quality care, as well as an underdeveloped component of AP practice. Understanding research-related attitudes and roles of APs could lead to enhanced clinical trial accrual, conduct, and protocol development. METHODS: A nationwide survey addressing attitudes, beliefs, and roles of APs regarding clinical research was distributed by the Association of Community Cancer Centers (ACCC) and Harborside in early 2020. RESULTS: 408 oncology APs completed the survey. Thirty-five percent practice in an academic setting and 62% in the community. Nearly all respondents believe clinical trials are important to improve care, and over 90% report clinical trials are available at their practice. About 80% report being comfortable discussing the topic of clinical trials with patients and are involved in the care of trial participants. Sixty percent are comfortable discussing available trials, and 38% routinely explore available trials with patients. While 70% report approaching eligible patients about trials, only 20% report doing so “a great deal” or “a lot.” Ninety percent report that APs should play a role in clinical research, and 73% want to be more involved. Barriers identified to greater AP clinical trial involvement include lack of time, inadequate awareness of trial specifics, and a lack of a formal role in protocol development and leadership. CONCLUSIONS: Advanced practitioners are engaged and interested in clinical trials and believe clinical research is important to improve cancer care. Multidisciplinary team integration, trials-related education, and policy change are needed to employ APs to their full potential within cancer clinical trials.
format Online
Article
Text
id pubmed-8955568
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-89555682022-04-01 Role of Oncology Advanced Practitioners to Enhance Clinical Research Braun-Inglis, Christa Boehmer, Leigh M. Zitella, Laura J. Hoffner, Brianna Shvetsov, Yurii B. Berenberg, Jeffrey L. Oyer, Randall A. Benson, Al B. J Adv Pract Oncol Research & Scholarship BACKGROUND: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance value across the spectrum of cancer care. Research is an underdeveloped component of quality care, as well as an underdeveloped component of AP practice. Understanding research-related attitudes and roles of APs could lead to enhanced clinical trial accrual, conduct, and protocol development. METHODS: A nationwide survey addressing attitudes, beliefs, and roles of APs regarding clinical research was distributed by the Association of Community Cancer Centers (ACCC) and Harborside in early 2020. RESULTS: 408 oncology APs completed the survey. Thirty-five percent practice in an academic setting and 62% in the community. Nearly all respondents believe clinical trials are important to improve care, and over 90% report clinical trials are available at their practice. About 80% report being comfortable discussing the topic of clinical trials with patients and are involved in the care of trial participants. Sixty percent are comfortable discussing available trials, and 38% routinely explore available trials with patients. While 70% report approaching eligible patients about trials, only 20% report doing so “a great deal” or “a lot.” Ninety percent report that APs should play a role in clinical research, and 73% want to be more involved. Barriers identified to greater AP clinical trial involvement include lack of time, inadequate awareness of trial specifics, and a lack of a formal role in protocol development and leadership. CONCLUSIONS: Advanced practitioners are engaged and interested in clinical trials and believe clinical research is important to improve cancer care. Multidisciplinary team integration, trials-related education, and policy change are needed to employ APs to their full potential within cancer clinical trials. Harborside Press LLC 2022-03 2022-03-25 /pmc/articles/PMC8955568/ /pubmed/35369396 http://dx.doi.org/10.6004/jadpro.2022.13.2.2 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research & Scholarship
Braun-Inglis, Christa
Boehmer, Leigh M.
Zitella, Laura J.
Hoffner, Brianna
Shvetsov, Yurii B.
Berenberg, Jeffrey L.
Oyer, Randall A.
Benson, Al B.
Role of Oncology Advanced Practitioners to Enhance Clinical Research
title Role of Oncology Advanced Practitioners to Enhance Clinical Research
title_full Role of Oncology Advanced Practitioners to Enhance Clinical Research
title_fullStr Role of Oncology Advanced Practitioners to Enhance Clinical Research
title_full_unstemmed Role of Oncology Advanced Practitioners to Enhance Clinical Research
title_short Role of Oncology Advanced Practitioners to Enhance Clinical Research
title_sort role of oncology advanced practitioners to enhance clinical research
topic Research & Scholarship
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955568/
https://www.ncbi.nlm.nih.gov/pubmed/35369396
http://dx.doi.org/10.6004/jadpro.2022.13.2.2
work_keys_str_mv AT brauninglischrista roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT boehmerleighm roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT zitellalauraj roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT hoffnerbrianna roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT shvetsovyuriib roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT berenbergjeffreyl roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT oyerrandalla roleofoncologyadvancedpractitionerstoenhanceclinicalresearch
AT bensonalb roleofoncologyadvancedpractitionerstoenhanceclinicalresearch